荣昌生物制药（烟台）股份有限公司致力于发现、开发和商业化同类首创(first-in-class)和同类最佳 (best-in-class)的生物药物，不断创造新的临床价值，满足尚未被满足的重大临床需求，成为全球生物制药行业的领军企业。
Employees: 11-50
Investors 1
| Date | Name | Website |
| 09.02.2022 | Matrix Par... | matrixpart... |
Mentions in press and media 17
| Date | Title | Description | Source |
| 27.09.2023 | Remegen's Innovative New Drug Telitacicept(RC18) Obtains Pos... | YANTAI, China, Sept. 27, 2023 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Co... | en.prnasia... |
| 25.07.2023 | RemeGen's Telitacicept Shows Significant Promise in Phase II... | YANTAI, China, July 25, 2023 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Com... | en.prnasia... |
| 10.07.2023 | RemeGen and Innovent Collaborate on Clinical Trials to Evalu... | The partnership focuses on combining novel antibody-drug conjugates RC88 and RC108 with a PD-1 inhib... | en.prnasia... |
| 05.06.2023 | RemeGen Demonstrates Profitability to Successfully Receive A... | The "B" marker is removed from the Company's stock short name YANTAI, China, June 5, 2023... | en.prnasia... |
| 26.04.2023 | RemeGen Celebrates World Intellectual Property Day 2023 | YANTAI, China, April 26, 2023 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Co... | en.prnasia... |
| 28.02.2023 | On Rare Disease Day 2023 RemeGen Highlights Its Social Respo... | YANTAI, China, Feb. 28, 2023 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Com... | en.prnasia... |
| 13.12.2022 | RemeGen's RC118 for Injection Targeting Claudin 18.2 in Pati... | YANTAI, China, Dec. 13, 2022 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Com... | en.prnasia... |
| 17.11.2022 | RemeGen's Disitamab Vedotin Achieves First-Line Treatment Re... | YANTAI, China, Nov. 17, 2022 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Com... | en.prnasia... |
| 01.11.2022 | RemeGen Releases Phase II Clinical Study Data for Treatment ... | YANTAI, China, Nov.1, 2022 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Compa... | en.prnasia... |
| 13.10.2022 | RemeGen Receives Orphan Drug Designation from FDA for Telita... | YANTAI, China, Oct. 13, 2022 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Com... | en.prnasia... |
Show more